Six Chinese Children with PDE: What Their EEGs and Gene Variants Can Teach Us About Early Recognition

A case series summarizes seizure patterns, EEG changes, and ALDH7A1 variant findings in six children, emphasizing that early pyridoxine can normalize EEG and improve long-term outlook. Even within PDE-ALDH7A1, families can see very different seizure types and severity. This report reviews six children treated from 2017 to 2023, with most starting seizures in the neonatal […]

A Devastating Reminder: Refractory Neonatal Seizures, Hyperammonemia, and an ALDH7A1 Diagnosis

A neonatal case report describes multifocal seizures with severe metabolic instability and a confirmed ALDH7A1 pathogenic variant, stressing how urgent early recognition can be.

Newborn Screening for PDE: A High-Throughput Lab Workflow Using 2-OPP, Oxo-PIP, and Pipecolate

A methods-and-performance study supports adding PDE-ALDH7A1 to existing newborn screening systems by measuring 2-OPP and confirmatory markers in a single FIA-MS/MS assay.

17 Patients, 15 Years of Practice: What a PDE Center Cohort Learned About Lysine-Restricted Diet (and Arginine)

A center cohort study tracks biochemical changes and practical adherence issues with lysine reduction therapies in 17 PDE-ALDH7A1 patients.

Proof-of-Concept: Blocking LKR Upstream Can Prevent Toxic Metabolite Build-Up and Rescue Brain Function in a PDE Mouse Model

A mouse genetics study shows that disrupting lysine alpha-ketoglutarate reductase (LKR) upstream of ALDH7A1 can eliminate toxic intermediates and reverse seizures and cognitive deficits in an ALDH7A1-deficient model.

What’s the Evidence for “Triple Therapy” in PDE? A Systematic Review of B6, Lysine Restriction, and Arginine

A systematic review compares pyridoxine alone versus adding lysine-restricted diet and/or arginine, with a focus on seizure control and neurodevelopmental outcomes.

Research Highlight: Monitoring Liver Health During Long-Term PLP Therapy

What this is This is a case report discussing potential long-term liver safety concern in some children treated with high-dose pyridoxal-5′-phosphate (PLP). CurePDE shares this to keep our community informed, not to provide treatment guidance. Paper links: PubMed (PMID 41429136) DOI: 10.1055/a-2773-6076 Key points A small report described 4 children with vitamin B6-dependent epilepsies who […]

What We’ve Been Up To! A Year In Review + Family Retreat Preview

If you read our blogs, it’s time to catch you up! 📍 Family Retreat – October 3–5, 2025 – Aurora, CO Let’s start with some exciting news: our PDE Family Retreat is happening October 3–5, 2025, in beautiful Aurora, Colorado!One of the highlights this year will be a special tour of the Coughlin Lab at the University of Colorado […]

Summary of Dietary Guidelines for PDE 2024

Understanding Pyridoxine-Dependent Epilepsy and Dietary Management: A Guide for Families.

© 2023 Cure PDE Foundation | All Rights Reserved | Terms of Use | Privacy Policy | Site Credit